These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8749657)

  • 21. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin resistant enterococci in hospitals in the United Kingdom--1995.
    Commun Dis Rep CDR Wkly; 1996 Aug; 6(31):267. PubMed ID: 8791882
    [No Abstract]   [Full Text] [Related]  

  • 23. Vancomycin-resistant Enterococcus faecium colonisations.
    Ferguson J; Butt H; Johnson C; Boyle M
    Med J Aust; 1996 Sep; 165(5):292-3. PubMed ID: 8816691
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci.
    Hachem R; Raad I
    Infect Control Hosp Epidemiol; 2002 Jan; 23(1):43-4. PubMed ID: 11868893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of vancomycin-resistant Enterococcus faecium infections in a liver transplant unit.
    Hill RL; Chen HY; Kirk M; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():293-7. PubMed ID: 9331656
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial resistance classification using MALDI-TOF-MS is not that easy: lessons from vancomycin-resistant Enterococcus faecium.
    Brackmann M; Leib SL; Tonolla M; Schürch N; Wittwer M
    Clin Microbiol Infect; 2020 Mar; 26(3):391-393. PubMed ID: 31682986
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
    Hagman HM; Strausbaugh LJ
    Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients.
    Koc Y; Snydman DR; Schenkein DS; Miller KB
    Bone Marrow Transplant; 1998 Jul; 22(2):207-9. PubMed ID: 9707033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of vancomycin-resistant enterococci in South Africa.
    Budavari SM; Saunders GL; Liebowitz LD; Khoosal M; Crewe-Brown HH
    S Afr Med J; 1997 Nov; 87(11):1557. PubMed ID: 9472288
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    Tan TY; Pitman I; Penrose-Stevens A; Simpson BA; Flanagan PG
    J Infect; 2000 Jul; 41(1):95-7. PubMed ID: 11041712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical management of patients infected with resistant organisms: an infection control perspective.
    Boyce JM
    Adv Exp Med Biol; 1995; 390():177-86. PubMed ID: 8718612
    [No Abstract]   [Full Text] [Related]  

  • 33. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Tush GM; Huneycutt S; Phillips A; Ward JD
    Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
    [No Abstract]   [Full Text] [Related]  

  • 34. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
    Jenkins I
    J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium.
    Montecalvo MA; Horowitz H; Wormser GP; Seiter K; Carbonaro CA
    Antimicrob Agents Chemother; 1995 Mar; 39(3):794. PubMed ID: 7793898
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
    Nourse C; Murphy H; Byrne C; O'Meara A; Breatnach F; Kaufmann M; Clarke A; Butler K
    Eur J Pediatr; 1998 Jan; 157(1):20-7. PubMed ID: 9461358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
    Stosor V; Peterson LR; Postelnick M; Noskin GA
    Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center.
    McNeeley DF; Brown AE; Noel GJ; Chung M; De Lencastre H
    Pediatr Infect Dis J; 1998 Mar; 17(3):184-8. PubMed ID: 9535243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterococcus faecium in hospitals.
    Wade JJ
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):113-9. PubMed ID: 9105837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of colonization with vancomycin-resistant Enterococcus faecium.
    Roghmann MC; Qaiyumi S; Schwalbe R; Morris JG
    Infect Control Hosp Epidemiol; 1997 Oct; 18(10):679-80. PubMed ID: 9350457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.